Antheia advances API biomanufacturing
Company’s SynBio platform enables manufacturing of complex plant-based drugs Biomanufacturing and synthetic biology (SynBio) manufacturing platforms have the potential to create more resilient supply chains for essential medicines by producing…
Investing in the next wave of biomanufacturing technologies for pharma
The global pandemic has brought pharmaceutical manufacturing to the forefront of America’s public consciousness. Acute drug shortages brought on by COVID-19 have underscored the need for domestic production and more resilient supply chains…
Scaling synthetic biology as a manufacturing platform
For decades, synthetic biology has promised to make manufacturing more efficient, sustainable, and responsive to sudden changes in supply and demand. It has the potential to create new value across industries by transforming everything from food to pharmaceuticals…